BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Yersinia

Below is an extended Yersinia research listing. Click here to return to the Yersinia main in depth entry.

Recent Publications on Yersinia:

Cross-reaction between Yersinia outer membrane proteins and anti-Borrelia antibodies in sera of patients with Lyme disease.
Diagnosis of Yersinia infections accompanied by reactive arthritis could...
Direct Link
11th October, 2008
Department of Pathogenic Bacteria, The Stephan Angeloff Institute of
Immune defense against pneumonic plague.
SUMMARY: Yersinia pestis is one of the world's most virulent human...
Direct Link
8th October, 2008
Trudeau Institute, Saranac Lake, NY 12983, USA.
IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: Implications for its use as oral carrier vaccine.
Yersinia enterocolitica (Ye) mutant strain (sycH-) is unable to secrete...
Direct Link
7th October, 2008
Immunology, Laboratory of Microbiology, Chemistry, Biochemistry and
A novel DNA microarray for rapid diagnosis of enteropathogenic bacteria in stool specimens of patients with diarrhea.
A microarray technique for the detection and identification of...
Direct Link
7th October, 2008
National Institute for Communicable Disease Control and Prevention,
Yersinia pestis evades TLR4-dependent induction of IL-12(p40)2 by dendritic cells and subsequent cell migration. 4th October, 2008
Trudeau Institute, Saranac Lake, NY 12983, USA.
Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4(+) cells are required at the time of challenge for optimal protection.
We have developed an experimental recombinant vesicular stomatitis virus...
Direct Link
4th October, 2008
Department of Pathology, Yale University School of Medicine, 310 Cedar
Engineered Saccharomyces cerevisiae strain for improved xylose utilization with a three-plasmid SUMO yeast expression system.
A three-plasmid yeast expression system utilizing the portable small...
Direct Link
4th October, 2008
United States Department of Agriculture (USDA), Agricultural Research
Interleukin-12p40 contributes to protection against lung injury after oral Yersinia enterocolitica infection.
OBJECTIVE: The impact of Yersinia enterocolitica on lung is incompletely...
Direct Link
2nd October, 2008
Laboratorio de Bioquimica Molecular - Universidad Nacional de San Luis -
Source of host blood affects prevalence of infection and bacterial loads of Yersinia pestis in fleas. 2nd October, 2008
Bacterial Diseases Branch, Division of Vector Borne Infectious Diseases,
Role of connexin-43 hemichannels in the pathogenesis of Yersinia enterocolitica.
Connexin (Cx) channels are sites of cytoplasmic communication between...
Direct Link
1st October, 2008
Dipartimento di Patologia e Sanita Animale, Universita di Napoli Federico
Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease.
Arthralgia and spondyloarthropathy of the peripheral and the axial joints...
Direct Link
1st October, 2008
Department of Pathology, VU University Medical Centre, Amsterdam, The
Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
Attenuated enteropathogenic yersiniae that translocate heterologous...
Direct Link
30th September, 2008
Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie,
Characterisation of aerobically grown non-spore-forming bacteria from paper mill pulps containing recycled fibres.
A total of 179 non-spore-forming bacteria aerobically growing on Nutrient...
Direct Link
30th September, 2008
VTT Technical Research Centre of Finland, Tietotie 2, Espoo, P.O. Box
[Evaluation of antigenic properties of Campylobacter jejuni and Campylobacter coli proteins in a western-immunoblot] 30th September, 2008
Zaklad Bakteriologii NIZP--PZH w Warszawie.
[Role of Yersinia pestis biofilms in mechanisms of plague enzootics] 30th September, 2008
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional